- Home
- INTS vs ABTS Comparison
INTS vs ABTS Comparison
Compare INTS & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- ABTS
- Stock Information
- Founded
- INTS 2012
- ABTS 2010
- Country
- INTS United States
- ABTS Hong Kong
- Employees
- INTS N/A
- ABTS N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- ABTS Computer Software: Programming Data Processing
- Sector
- INTS Health Care
- ABTS Technology
- Exchange
- INTS Nasdaq
- ABTS Nasdaq
- Market Cap
- INTS 8.4M
- ABTS 9.8M
- IPO Year
- INTS 2023
- ABTS N/A
- Fundamental
- Price
- INTS $0.30
- ABTS $3.75
- Analyst Decision
- INTS Strong Buy
- ABTS
- Analyst Count
- INTS 4
- ABTS 0
- Target Price
- INTS $4.50
- ABTS N/A
- AVG Volume (30 Days)
- INTS 5.8M
- ABTS 16.7K
- Earning Date
- INTS 08-07-2025
- ABTS 08-13-2025
- Dividend Yield
- INTS N/A
- ABTS N/A
- EPS Growth
- INTS N/A
- ABTS N/A
- EPS
- INTS N/A
- ABTS N/A
- Revenue
- INTS N/A
- ABTS $7,037,156.00
- Revenue This Year
- INTS N/A
- ABTS N/A
- Revenue Next Year
- INTS N/A
- ABTS N/A
- P/E Ratio
- INTS N/A
- ABTS N/A
- Revenue Growth
- INTS N/A
- ABTS 31.69
- 52 Week Low
- INTS $0.19
- ABTS $1.35
- 52 Week High
- INTS $4.35
- ABTS $14.10
- Technical
- Relative Strength Index (RSI)
- INTS 49.95
- ABTS 41.21
- Support Level
- INTS $0.28
- ABTS $3.99
- Resistance Level
- INTS $0.32
- ABTS $4.24
- Average True Range (ATR)
- INTS 0.03
- ABTS 0.27
- MACD
- INTS 0.01
- ABTS -0.02
- Stochastic Oscillator
- INTS 78.80
- ABTS 0.00
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations. The group has its subsidiaries in USA, China, Canada and Hong Kong.